Sarepta Therapeutics is navigating a transition from a profitable rare-disease company to a capital-intensive, multi-platform ...
Burger King president Tom Curtis was not dealing in hyperbole when he suggested the brand had “earned the right” to dial up ...
NORTHAMPTON, MA / ACCESS Newswire / March 24, 2026 / Originally published on GoDaddy Resource Library.By Joseph PalumboOver ...
Payment lists, audio recordings of conversations, and million-dollar bribes: details of the corruption cases in the Verkhovna ...
When we were studying Economics at the University of Ceylon, Prof. Buddhadasa Hewavitharana told us ‘When America sneezes, ...
Gilead Sciences plans to acquire Ouro Medicines, a developer of autoimmune-disease therapies, for up to about $2.18 billion and develop the assets from the deal in a collaboration with Galapagos.
It feels like every week there’s a new development in the world of AI startups, and keeping up can be a full-time job. But if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results